Thomas Charpeaud

1.6k total citations
20 papers, 197 citations indexed

About

Thomas Charpeaud is a scholar working on Psychiatry and Mental health, Philosophy and Pharmacology. According to data from OpenAlex, Thomas Charpeaud has authored 20 papers receiving a total of 197 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 4 papers in Philosophy and 3 papers in Pharmacology. Recurrent topics in Thomas Charpeaud's work include Schizophrenia research and treatment (10 papers), Bipolar Disorder and Treatment (4 papers) and Mental Health and Psychiatry (4 papers). Thomas Charpeaud is often cited by papers focused on Schizophrenia research and treatment (10 papers), Bipolar Disorder and Treatment (4 papers) and Mental Health and Psychiatry (4 papers). Thomas Charpeaud collaborates with scholars based in France, United States and Singapore. Thomas Charpeaud's co-authors include Pierre‐Michel Llorca, Ludovic Samalin, Ricardo P. Garay, Leslie Citrome, Ahcène Hameg, Christoph U. Correll, Carlos A. Zarate, Stephan Heres, Olivier Blanc and Franck Schürhoff and has published in prestigious journals such as The Journal of Nervous and Mental Disease, BMC Psychiatry and Journal of Clinical Medicine.

In The Last Decade

Thomas Charpeaud

19 papers receiving 193 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Charpeaud France 8 82 52 44 37 27 20 197
Kenya A. Costa-Dookhan Canada 9 193 2.4× 36 0.7× 38 0.9× 60 1.6× 29 1.1× 14 373
Nicole E. MacKenzie Canada 7 121 1.5× 26 0.5× 42 1.0× 38 1.0× 18 0.7× 18 277
A. Hasan Germany 9 157 1.9× 32 0.6× 40 0.9× 33 0.9× 27 1.0× 15 244
João Vian Portugal 6 77 0.9× 41 0.8× 21 0.5× 47 1.3× 17 0.6× 8 274
Astrid Röh Germany 6 188 2.3× 24 0.5× 34 0.8× 33 0.9× 13 0.5× 15 267
James E. Emanuel United States 8 177 2.2× 27 0.5× 25 0.6× 22 0.6× 25 0.9× 12 300
María Juncal‐Ruíz Spain 11 196 2.4× 26 0.5× 48 1.1× 67 1.8× 15 0.6× 22 288
Tom Denee United Kingdom 7 82 1.0× 125 2.4× 47 1.1× 69 1.9× 16 0.6× 21 266
Alba Toll Spain 8 128 1.6× 63 1.2× 70 1.6× 50 1.4× 36 1.3× 29 246
Lorenzo Del Fabro Italy 6 125 1.5× 45 0.9× 33 0.8× 37 1.0× 16 0.6× 9 272

Countries citing papers authored by Thomas Charpeaud

Since Specialization
Citations

This map shows the geographic impact of Thomas Charpeaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Charpeaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Charpeaud more than expected).

Fields of papers citing papers by Thomas Charpeaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Charpeaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Charpeaud. The network helps show where Thomas Charpeaud may publish in the future.

Co-authorship network of co-authors of Thomas Charpeaud

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Charpeaud. A scholar is included among the top collaborators of Thomas Charpeaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Charpeaud. Thomas Charpeaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sauvaget, Anne, Samuel Bulteau, Thomas Charpeaud, et al.. (2024). Prospective Acceptability of Digital Therapy for Major Depressive Disorder in France: Multicentric Real-Life Study. JMIR Formative Research. 8. e53204–e53204. 1 indexed citations
2.
3.
Gay, Aurélia, I. de Chazeron, Céline Lambert, et al.. (2022). Repetitive Transcranial Magnetic Stimulation (rTMS) as a Promising Treatment for Craving in Stimulant Drugs and Behavioral Addiction: A Meta-Analysis. Journal of Clinical Medicine. 11(3). 624–624. 24 indexed citations
4.
Garay, Ricardo P., Thomas Charpeaud, Susan Logan, et al.. (2019). Pharmacotherapeutic approaches to treating depression during the perimenopause. Expert Opinion on Pharmacotherapy. 20(15). 1837–1845. 16 indexed citations
5.
Garay, Ricardo P., Carlos A. Zarate, Thomas Charpeaud, et al.. (2017). Investigational drugs in recent clinical trials for treatment-resistant depression. Expert Review of Neurotherapeutics. 17(6). 593–609. 54 indexed citations
6.
7.
Szöke, Andreı̈, et al.. (2014). Rural-urban variation in incidence of psychosis in France: a prospective epidemiologic study in two contrasted catchment areas. BMC Psychiatry. 14(1). 78–78. 20 indexed citations
8.
Charpeaud, Thomas, Ludovic Samalin, & Pierre‐Michel Llorca. (2014). Efficacité de l’aripiprazole dans le traitement de la schizophrénie : quelle dose pour quel effet ?. L Encéphale. 40(1). 62–73. 4 indexed citations
9.
Charpeaud, Thomas, et al.. (2014). Intérêt de l’éducation thérapeutique chez les malades souffrant de schizophrénie : le programme SCHIZ’EDUC. Annales Médico-psychologiques revue psychiatrique. 173(1). 97–100. 3 indexed citations
10.
Samalin, Ludovic, Thomas Charpeaud, & Pierre‐Michel Llorca. (2014). Aripiprazole injectable à libération prolongée dans le traitement de maintenance de la schizophrénie. L Encéphale. 40(6). 487–494. 1 indexed citations
11.
Samalin, Ludovic, et al.. (2013). What is the evidence for the use of second-generation antipsychotic long-acting injectables as maintenance treatment in bipolar disorder?. Nordic Journal of Psychiatry. 68(4). 227–235. 17 indexed citations
12.
Samalin, Ludovic, Thomas Charpeaud, Olivier Blanc, Stephan Heres, & Pierre‐Michel Llorca. (2013). Clinicians’ Attitudes Toward the Use of Long-Acting Injectable Antipsychotics. The Journal of Nervous and Mental Disease. 201(7). 553–559. 26 indexed citations
13.
Chéreau‐Boudet, Isabelle, et al.. (2013). 1027 – Interests Of a Program Of Physical Activity In Patients With Schizophrenia: a Pilot Study. European Psychiatry. 28(S1). 1 indexed citations
14.
Samalin, Ludovic, Thomas Charpeaud, Stephan Heres, & Pierre‐Michel Llorca. (2013). 1151 – Clinicians’ Attitudes Toward The Use Of Long-acting Injectable Antipsychotics. European Psychiatry. 28(S1). 1 indexed citations
15.
Llorca, Pierre‐Michel, Thomas Charpeaud, & Ludovic Samalin. (2012). États mixtes. L Encéphale. 38. S179–S185. 1 indexed citations
16.
Charpeaud, Thomas, Ludovic Samalin, Olivier Blanc, & Pierre‐Michel Llorca. (2012). Attitudes of French psychiatrists toward antipsychotic depot medication in schizophrenia. L Encéphale. 38(4). S11–S12.
17.
Samalin, Ludovic, Thomas Charpeaud, & Pierre‐Michel Llorca. (2012). Asenapine in bipolar I disorder: evidence and place in patient management. Therapeutic Advances in Chronic Disease. 4(1). 5–14. 9 indexed citations
18.
Charpeaud, Thomas, et al.. (2011). Le disulfirame (Esperal®) dans le traitement des addictions : rappels et nouvelles perspectives d’utilisation. Therapies. 66(3). 273–280. 5 indexed citations
19.
Samalin, Ludovic, Thomas Charpeaud, & Sébastien Guillaume. (2011). Les recommandations professionnelles dans le traitement de la dépression bipolaire. L Encéphale. 37. S218–S223. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenya A. Costa-Dookhan Breakdown of academic impact, for papers by Nicole E. MacKenzie Breakdown of academic impact, for papers by A. Hasan Breakdown of academic impact, for papers by João Vian Breakdown of academic impact, for papers by Astrid Röh Breakdown of academic impact, for papers by James E. Emanuel Breakdown of academic impact, for papers by María Juncal‐Ruíz Breakdown of academic impact, for papers by Tom Denee Breakdown of academic impact, for papers by Alba Toll Breakdown of academic impact, for papers by Lorenzo Del Fabro
Rankless by CCL
2026